自体脂肪声带填充术长期临床结局的系统综述
该研究系统检索了截至2020年9月的文献,纳入31项研究共764例接受声带脂肪填充的患者,适应症主要为声带麻痹(690例)和声带萎缩(74例)。结果显示仅11例(1.4%)报告嗓音或吞咽无改善,1年内11.7%(71/608)出现回归基线,1年以上至8年12.6%(27/214)出现疗效减退,33例需额外手术。结论认为多数患者可获得长期获益,但疗效随时间逐渐减退。
要点
- 声带脂肪填充术对声带麻痹和萎缩患者长期有效,仅1.4%无改善。
- 1年内约11.7%患者疗效回归基线,1年以上至8年约12.6%出现疗效减退。
- 33例患者需接受额外手术,提示部分患者仍需后续干预。
核心结论
- 声带脂肪填充术后嗓音和吞咽改善随时间逐渐减退,但多数患者获得长期获益。
研究设计与样本
- 系统综述,遵循PRISMA指南,检索PubMed、MEDLINE、Cochrane Library和Web of Science(2020年9月),最终纳入31项研究共764例患者。
主要发现
- 适应症为声带麻痹690例和声带萎缩74例。
- 脂肪取材部位包括腹部(21项研究,529例)、大腿/腹部(5项研究,91例)和颊部/颏下(2项研究,33例)。
- 仅11/764例(1.4%)报告嗓音和/或吞咽无改善。
- 1年内71/608例(11.7%)报告回归基线;1年以上至8年27/214例(12.6%)报告疗效减退。
- 33例患者接受了额外手术。
临床怎么用
- 声带脂肪填充可用于声带麻痹或萎缩所致声门闭合不全,但需告知患者疗效可能随时间减退。
- 术后应长期随访嗓音和吞咽功能,必要时评估是否需要额外手术。
局限性
- 纳入研究中脂肪处理技术和注射体积存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Vocal fold (VF) lipoaugmentation can be employed to treat glottal insufficiency although variable data exist on its length of effectiveness. We aimed to review published long-term outcomes following lipoaugmentation across the literature and compile outcome data. STUDY DESIGN: Systematic review. METHODS: A systematic search in September 2020 of PubMed, MEDLINE, Cochrane Library, and Web of Science used the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines to identify 128 relevant articles related to VF lipoaugmentation effectiveness duration. Primary search terms included the following: vocal cord, fat, lipo, and atrophy. Forty-eight full-text articles were reviewed and 31 were included in the final analysis. Primary endpoints included the following: duration of effectiveness per patient-reported outcome measures, objective findings, and additional procedures performed. In addition, fat harvest location and processing techniques were recorded. FINDINGS: Thirty-one studies totaling 764 patients were included in the review. Indications for augmentation were VF paralysis (N = 690) and atrophy (N = 74). Fat was harvested from the abdominal region in 21 studies (529 patients), the thigh/abdomen in 5 studies (91 patients), and buccal/submental region in 2 studies (33 patients). Processing techniques and injectable volume varied. Across included studies, only 11 of 764 patients (1.4%) reported no improvement in voice and/or swallowing. Within the first year, 71 of 608 patients (11.7%) reported a regression toward baseline. Beyond 1 year and up to 8 years, 27 of 214 patients (12.6%) reported regression from initial improvement. Thirty-three patients underwent additional procedures. CONCLUSION: Although improvements in voice and swallowing after lipoaugmentation taper over time, most patients experienced long-term benefit. Laryngoscope, 132:1042-1053, 2022.
引用
- Luke AS, Logan AM, Gawlik AE, et al. Autologous Lipoaugmentation Long-Term Clinical Outcomes: A Systematic Review. Laryngoscope. 2021. PMID: 34375001. doi:10.1002/lary.29802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。